FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2100144002> ?p ?o ?g. }

• W2100144002 endingPage "232" @default.
• W2100144002 startingPage "226" @default.
• W2100144002 abstract "To assess the effect of dietary flavonoids on cardiovascular disease (CVD) risk in postmenopausal women with type 2 diabetes on established statin and hypoglycemic therapy.Despite being medicated, patients with type 2 diabetes have elevated CVD risk, particularly postmenopausal women. Although dietary flavonoids have been shown to reduce CVD risk factors in healthy participants, no long-term trials have examined the additional benefits of flavonoids to CVD risk in medicated postmenopausal women with type 2 diabetes. We conducted a parallel-design, placebo-controlled trial with type 2 diabetic patients randomized to consume 27 g/day (split dose) flavonoid-enriched chocolate (containing 850 mg flavan-3-ols [90 mg epicatechin] and 100 mg isoflavones [aglycone equivalents)]/day) or matched placebo for 1 year.Ninety-three patients completed the trial, and adherence was high (flavonoid 91.3%; placebo 91.6%). Compared with the placebo group, the combined flavonoid intervention resulted in a significant reduction in estimated peripheral insulin resistance (homeostasis model assessment of insulin resistance [HOMA-IR] -0.3 ± 0.2; P = 0.004) and improvement in insulin sensitivity (quantitative insulin sensitivity index [QUICKI] 0.003 ± 0.00; P = 0.04) as a result of a significant decrease in insulin levels (-0.8 ± 0.5 mU/L; P = 0.02). Significant reductions in total cholesterol:HDL-cholesterol (HDL-C) ratio (-0.2 ± 0.1; P = 0.01) and LDL-cholesterol (LDL-C) (-0.1 ± 0.1 mmol/L; P = 0.04) were also observed. Estimated 10-year total coronary heart disease risk (derived from UK Prospective Diabetes Study algorithm) was attenuated after flavonoid intervention (flavonoid +0.1 ± 0.3 vs. placebo 1.1 ± 0.3; P = 0.02). No effect on blood pressure, HbA(1c), or glucose was observed.One-year intervention with flavan-3-ols and isoflavones improved biomarkers of CVD risk, highlighting the additional benefit of flavonoids to standard drug therapy in managing CVD risk in postmenopausal type 2 diabetic patients." @default.
• W2100144002 created "2016-06-24" @default.
• W2100144002 creator A5000353299 @default.
• W2100144002 creator A5008575718 @default.
• W2100144002 creator A5023048944 @default.
• W2100144002 creator A5027209816 @default.
• W2100144002 creator A5049466011 @default.
• W2100144002 creator A5078506759 @default.
• W2100144002 date "2012-01-16" @default.
• W2100144002 modified "2023-10-11" @default.
• W2100144002 title "Chronic Ingestion of Flavan-3-ols and Isoflavones Improves Insulin Sensitivity and Lipoprotein Status and Attenuates Estimated 10-Year CVD Risk in Medicated Postmenopausal Women With Type 2 Diabetes" @default.
• W2100144002 cites W1500999143 @default.
• W2100144002 cites W1932605991 @default.
• W2100144002 cites W1992396691 @default.
• W2100144002 cites W1998018796 @default.
• W2100144002 cites W2033398393 @default.
• W2100144002 cites W2035569239 @default.
• W2100144002 cites W2036283295 @default.
• W2100144002 cites W2041696073 @default.
• W2100144002 cites W2044076817 @default.
• W2100144002 cites W2046864840 @default.
• W2100144002 cites W2047459103 @default.
• W2100144002 cites W2054633560 @default.
• W2100144002 cites W2076110050 @default.
• W2100144002 cites W2089770071 @default.
• W2100144002 cites W2095887024 @default.
• W2100144002 cites W2097164792 @default.
• W2100144002 cites W2097870088 @default.
• W2100144002 cites W2100116730 @default.
• W2100144002 cites W2100478675 @default.
• W2100144002 cites W2111367158 @default.
• W2100144002 cites W2113303300 @default.
• W2100144002 cites W2115985079 @default.
• W2100144002 cites W2116404316 @default.
• W2100144002 cites W2118447955 @default.
• W2100144002 cites W2120059732 @default.
• W2100144002 cites W2124373914 @default.
• W2100144002 cites W2126327417 @default.
• W2100144002 cites W2131911826 @default.
• W2100144002 cites W2140590679 @default.
• W2100144002 cites W2143536568 @default.
• W2100144002 cites W2144618543 @default.
• W2100144002 cites W2146862977 @default.
• W2100144002 cites W2147663252 @default.
• W2100144002 cites W2149402195 @default.
• W2100144002 cites W2155418053 @default.
• W2100144002 cites W2160234571 @default.
• W2100144002 doi "https://doi.org/10.2337/dc11-1443" @default.
• W2100144002 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3263874" @default.
• W2100144002 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22250063" @default.
• W2100144002 hasPublicationYear "2012" @default.
• W2100144002 type Work @default.
• W2100144002 sameAs 2100144002 @default.
• W2100144002 citedByCount "170" @default.
• W2100144002 countsByYear W21001440022012 @default.
• W2100144002 countsByYear W21001440022013 @default.
• W2100144002 countsByYear W21001440022014 @default.
• W2100144002 countsByYear W21001440022015 @default.
• W2100144002 countsByYear W21001440022016 @default.
• W2100144002 countsByYear W21001440022017 @default.
• W2100144002 countsByYear W21001440022018 @default.
• W2100144002 countsByYear W21001440022019 @default.
• W2100144002 countsByYear W21001440022020 @default.
• W2100144002 countsByYear W21001440022021 @default.
• W2100144002 countsByYear W21001440022022 @default.
• W2100144002 countsByYear W21001440022023 @default.
• W2100144002 crossrefType "journal-article" @default.
• W2100144002 hasAuthorship W2100144002A5000353299 @default.
• W2100144002 hasAuthorship W2100144002A5008575718 @default.
• W2100144002 hasAuthorship W2100144002A5023048944 @default.
• W2100144002 hasAuthorship W2100144002A5027209816 @default.
• W2100144002 hasAuthorship W2100144002A5049466011 @default.
• W2100144002 hasAuthorship W2100144002A5078506759 @default.
• W2100144002 hasBestOaLocation W21001440021 @default.
• W2100144002 hasConcept C126322002 @default.
• W2100144002 hasConcept C134018914 @default.
• W2100144002 hasConcept C142724271 @default.
• W2100144002 hasConcept C204787440 @default.
• W2100144002 hasConcept C27081682 @default.
• W2100144002 hasConcept C2777180221 @default.
• W2100144002 hasConcept C2777391703 @default.
• W2100144002 hasConcept C2778270857 @default.
• W2100144002 hasConcept C2778535154 @default.
• W2100144002 hasConcept C2778562196 @default.
• W2100144002 hasConcept C2779306644 @default.
• W2100144002 hasConcept C2779705811 @default.
• W2100144002 hasConcept C555293320 @default.
• W2100144002 hasConcept C71924100 @default.
• W2100144002 hasConceptScore W2100144002C126322002 @default.
• W2100144002 hasConceptScore W2100144002C134018914 @default.
• W2100144002 hasConceptScore W2100144002C142724271 @default.
• W2100144002 hasConceptScore W2100144002C204787440 @default.
• W2100144002 hasConceptScore W2100144002C27081682 @default.
• W2100144002 hasConceptScore W2100144002C2777180221 @default.
• W2100144002 hasConceptScore W2100144002C2777391703 @default.
• W2100144002 hasConceptScore W2100144002C2778270857 @default.
• W2100144002 hasConceptScore W2100144002C2778535154 @default.
• W2100144002 hasConceptScore W2100144002C2778562196 @default.

• next